A MoS2 based silver-doped ZnO nanocomposite and its antibacterial activity against β-lactamase expressing Escherichia

Atanu Naskar1, Joonho Shin1, Kwang-Sun Kim1

  • 1Department of Chemistry and Chemistry Institute for Functional Materials, Pusan National University Busan 46241 South Korea kwangsun.kim@pusan.ac.kr +82-51-516-7421 +82-51-510-2241.

RSC Advances
|April 15, 2022
PubMed

Insights

A novel molybdenum disulfide (MoS2)-based nanocomposite with silver-doped zinc oxide shows potent antibacterial activity against multidrug-resistant Escherichia coli. This nano-antibacterial platform offers selective targeting of specific bacterial resistance mechanisms.

Area of Science:

  • Materials Science
  • Nanotechnology
  • Microbiology
  • Infectious Diseases

Background:

  • Multidrug-resistant (MDR) Gram-negative bacteria, such as Escherichia coli, pose a significant global health threat due to increasing antibiotic resistance.
  • Two-dimensional (2D) nanomaterials, particularly molybdenum disulfide (MoS2) nanosheets, exhibit promising physicochemical properties for developing novel antibacterial strategies.
  • MoS2's high surface area, conductivity, and surface retention make it suitable for bactericidal applications.

Purpose of the Study:

  • To fabricate and characterize a MoS2-based nanocomposite conjugated with silver-doped zinc oxide (AZM) as an effective antibacterial agent.
  • To evaluate the antibacterial activity of AZM against various multidrug-resistant E. coli strains with different resistance mechanisms.
  • To investigate the role of MoS2 in enhancing AZM's antibacterial efficacy and selectivity.

Main Methods:

  • Fabrication of a MoS2-AZM nanocomposite.
  • Characterization of the AZM nanocomposite properties.
  • Evaluation of antibacterial activity against MDR E. coli strains, including those expressing β-lactamases and the mobilized colistin resistance (mcr-1) gene.

Main Results:

  • The MoS2-AZM nanocomposite demonstrated effective antibacterial activity against MDR E. coli.
  • MoS2 enhanced AZM's antibacterial activity and provided selectivity against MDR E. coli strains expressing β-lactamases.
  • Bacterial cell wall membrane disruption was identified as the primary cell death mechanism; surface charge perturbation explained differential activity against strains with β-lactamase and mcr-1 resistance.

Conclusions:

  • A MoS2-based nanocomposite with a functional conjugation strategy presents a promising selective nano-antibacterial platform.
  • This platform is effective against infections caused by MDR E. coli, particularly those resistant to β-lactam antibiotics.
  • The findings highlight the potential of tailored nanomaterials for combating challenging bacterial infections.

Related Concept Videos

Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Microbial Corrosion01:24

Microbial Corrosion

Microbiologically Influenced Corrosion (MIC) is a significant form of material degradation caused by the metabolic activities of microorganisms. This phenomenon poses substantial challenges across various industries, including oil and gas, maritime, and water treatment sectors.MIC occurs when microorganisms, such as bacteria, archaea, and fungi, colonize metal surfaces, forming biofilms that alter the local electrochemical environment. These biofilms can lead to the production of corrosive...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...